Hostname: page-component-54dcc4c588-smtgx Total loading time: 0 Render date: 2025-10-11T09:48:29.967Z Has data issue: false hasContentIssue false

Carbapenem Resistance in Three Hospitals in India: A Need for Strengthening Infection Prevention and Control Practices

Published online by Cambridge University Press:  24 September 2025

Bharat Randive
Affiliation:
B J Government Medical College-Johns Hopkins Clinical Research Site, Pune, India
Akash Patel
Affiliation:
Johns Hopkins Center for Infectious Diseases in India, Pune, India
Rajesh Karyakarte
Affiliation:
Johns Hopkins Hospital, Baltimore, Maryland, USA
Shaoli Basu
Affiliation:
Department of Microbiology, Byramjee Jeejeebhoy Government Medical College, Pune, India
Shahzad Mirza
Affiliation:
B J Government Medical College-Johns Hopkins Clinical Research Site, Pune, India
Sweety Singh
Affiliation:
Department of Laboratory Medicine, P. D. Hinduja National Hospital and Medical Research Centre, Mumbai, India
Mrunmayi Naik
Affiliation:
Department of Microbiology, Dr. D. Y. Patil Medical College, Hospital and Research Centre, Dr. D. Y. Patil Vidyapeeth University, Pune, Maharashtra, India
Kavita Sangma
Affiliation:
Johns Hopkins Center for Infectious Diseases in India, Pune, India
Sarah Fisseha
Affiliation:
Johns Hopkins Center for Infectious Diseases in India, Baltimore, Maryland, USA
Anushruti Gupta
Affiliation:
Centers for Disease Control & Prevention, Division of Healthcare Quality Promotion, Atlanta, GA, USA
Sarah Sabour
Affiliation:
Centers for Disease Control & Prevention, Division of Healthcare Quality Promotion, Atlanta, GA, USA
Meghan Murray
Affiliation:
Centers for Disease Control & Prevention, Division of Healthcare Quality Promotion, Atlanta, GA, USA
Amelia S. Bhatnagar
Affiliation:
Centers for Disease Control & Prevention, Division of Healthcare Quality Promotion, Atlanta, GA, USA
Matthew L Robinson
Affiliation:
Centers for Disease Control & Prevention, Division of Healthcare Quality Promotion, Atlanta, GA, USA
Melanie Curless
Affiliation:
Centers for Disease Control & Prevention, Division of Healthcare Quality Promotion, Atlanta, GA, USA
Patricia J Simner
Affiliation:
Centers for Disease Control & Prevention, Division of Healthcare Quality Promotion, Atlanta, GA, USA

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

Background: Carbapenem-resistant (CR) organisms (CROs) pose a serious public health threat. We examined the burden of CRO colonization, the proportion of CROs among clinical isolates, and infection prevention and control (IPC) practices in three hospitals in India. Methods: This study was conducted December 2023 to December 2024 in medical intensive care units (ICUs) at three hospitals in western India. CRO colonization was assessed by direct MacConkey method in rectal/stool specimens collected ≤24 hours after admission and weekly until colonization detection or ICU discharge, colonies < 25mm from carbapenem disks were processed for bacterial identification and carbapenem susceptibility. Proportion of CROs in clinical isolates was assessed by screening Gram-negative bacilli (GNB) identified for carbapenem susceptibility. CRO was defined as GNB resistant to any carbapenem. Carbapenemase production among Enterobacterales was detected by modified carbapenem inactivation method (mCIM). Fifty day shift hand hygiene (HH) observations were collected weekly to measure adherence. Fluorescent gel markers (FGM) were placed on high-touch surfaces (HTS) to assess environmental cleaning (EC); effectiveness was assessed by proportion of FGM removed the following day. Nine key EC indicators were observed weekly to monitor cleaning technique. HH and EC data included were from June 2024 to November 2024.

The epidemiological triad model (Population-Environment-Agent) is used to describe results. Results: Population: Over half (476 [55%]) of 869 patients screened at ICU admission were colonized with CROs. An equal proportion of colonization was observed among patients without prior healthcare exposure in last 90 days (55% [217/396]). Of the 660 GNBs isolated from clinical specimens, 60% were CROs. Environment: CRO colonization was acquired by 65% (20/31) of the patients who remained in ICU for ≥ 7 days. Average HH adherence was 50% (30%-69%). HTS cleaning effectiveness averaged 65% (50%-77%). Adherence with correct EC technique was 77% (53%-86%). Agent: Among clinical isolates, 92% Acinetobacter-baumannii-complex, 70% Klebsiella pneumoniae, and 47% Escherichia coli were CRO. K. pneumoniae (35%) was the most frequently isolated CRO followed by A.baumannii-complex (33%) and E.coli (16%). Among colonization screening swabs, E.coli (57%) was the most frequently isolated CRO followed by K. pneumoniae (23%) and A.baumannii-complex (10%). 96% of CR Enterobacterales among clinical isolates and colonization screening were carbapenemase producers. Conclusions: The high prevalence of CRO colonization, acquisition rate, and carbapenem resistance indicate a high level of CRO threat in these Indian ICU settings with suboptimal IPC measures. There is an urgent need to strengthen IPC practices to interrupt transmission in healthcare settings.

Information

Type
Infection Prevention in Low and Middle-Income Countries
Creative Commons
Creative Common License - CCCreative Common License - BY
This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
Copyright
© The Author(s), 2025. Published by Cambridge University Press on behalf of The Society for Healthcare Epidemiology of America